Clinical Trial Update: Special Drug Use Investigation for LAMICTAL® (Long Term)

View source ↗

Summary

A long-term Special Drug Use Investigation of LAMICTAL (lamotrigine) for epilepsy has completed. The sponsor is GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LAMICTAL (LAMOTRIGINE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Status: COMPLETED